An increase of more than @ pg/ml VEGFA and a decrease of more than @ % of the pre-therapeutic value of TIMP@ were significantly associated with a higher risk of early recurrence ( RR = @ , @ % CI = @-@ @ and RR = @ , @ % CI = @-@ @ , respectively ) .